New pill targets HIV in early human trial
Disease control
Recruiting now
This study is testing a new oral drug, STP0404, to see if it safely lowers the amount of HIV virus in people who are not currently on treatment. It will involve 36 adults with HIV-1 who have taken little or no HIV medication before. Researchers will measure the change in virus le…
Phase: PHASE2 • Sponsor: ST Pharm Co., Ltd. • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC